Assistant Professor, Medicine, University Massachusetts Medical School

Oncology

Bilal Piperdi, MD is an expert in the field of Oncology. He went to Albert Einstein College of Medicine. Bilal Piperdi is a published doctor as well. He has 22 publications published. The latest was: Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer. Doctor Bilal Piperdi, MD accepts Medicare.

Publications

---

• Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung Cancer.
• Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer.
• The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib.
• Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.
• Long-Term Disease Control With Sunitinib in a Patient With Metastatic Pancreatic Neuroendocrine Tumor (NET) Associated With Von Hippel-Lindau Syndrome (VHL).
• Bortezomib: understanding the mechanism of action.
• The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Ana...
• Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors.
• Treating hepatocellular Carcinoma with sorafenib in liver transplant patients: an initial experience.
• Human Barrett's adenoCarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transpl...
• A neoadjuvant strategy for pancreatic adenoCarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.
• A national propensity-adjusted Analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
• Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on s...
• KRAS mutation in colon Cancer: a marker of resistance to EGFR-I therapy.
• CytoreDuctive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis.
• Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung Cancer (NSCLC).
• Coronary vasospasm with myocardial stunning in a patient with colon Cancer receiving adjuvant chemotherapy with FOLFOX regimen.
• Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour.
• A misfired Greenfield filter; 21 years later!
• Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung Cancer cell lines.
• Phase II study of a liposome-entrapped cisplatin Analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheli...

Schools

---

• Ankara Universitesi Tip Fakultesi

• SUNY Upsate Med University

• Albert Einstein Med Center

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• Albert Einstein College of Medicine
• SUNY Upstate Medical University

Hospital

---

• Montefiore Medical Center
• UMass Memorial Medical Center

Drug Facts

---

NPI NUMBER		1063495901
NPPES Provider LastName		PIPERDI
NPPES Provider FirstName		BILAL
NPPES Provider ZIPCode		016550002
NPPES Provider State		MA
Specialty Description		Medical Oncology
Total Claim Count		240.0
Distinct Opioid Count		1.0
Opioid Claim Count		11.0
Percent Opioid Claims		4.58

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1063495901
Last Name Of The Provider	PIPERDI
First Name Of The Provider	BILAL
View All

Similar Doctors

---

	Dr. Abhishek Tripathi, MD This Doctor is OpenDoctor Recommended.
	Dr. Tariq I. Mughal, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mercedes E. Menendez, MD This Doctor is OpenDoctor Recommended.
	Dr. Vijay K. Kasturi, MD This Doctor is OpenDoctor Recommended.
	Dr. Nahida Islam, MD This Doctor is OpenDoctor Recommended.
	Dr. Mary E. Costanza, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jan Cerny, MD This Doctor is OpenDoctor Recommended.
	Dr. Suyang Hao, MD This Doctor is OpenDoctor Recommended.
	Dr. Athanasius A. Anagnostou, MD This Doctor is OpenDoctor Recommended.
	Dr. Olga Pozdnyakova, MD
	Dr. Herbert M. Dean, MD This Doctor is OpenDoctor Recommended.
	Dr. Alan Rosmarin, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Amr R. Hassan, MD This Doctor is OpenDoctor Recommended.
	Dr. John E. Scola, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog